Evidence map›Paper›PMID 23357388›Full record

ArticleInfection and immunity2013

RfaL is required for Yersinia pestis type III secretion and virulence.

Andrew S Houppert, Lesley Bohman, Peter M Merritt, Christopher B Cole, Adam J Caulfield, Wyndham W Lathem, Melanie M Marketon

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrew S HouppertDepartment of Biology, Indiana University, Bloomington, Indiana, USA.
Lesley Bohman
Peter M Merritt
Christopher B Cole
Adam J Caulfield
Wyndham W Lathem
Melanie M Marketon
Indiana University Bloomington · USNorthwestern University · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
TRAINING PROGRAM IN IMMUNOLOGY &MOLECULAR PATHOGENESIST32AI007476 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Edward Benjamin Thorp · 1996 to 2026
$6.6M
Role of the Plasminogen Activator Protease during Pneumonic PlagueR01AI093727 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LATHEM, WYNDHAM W. · 2011 to 2017
$2.3M
NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS R01 AI093727NIAID NIH HHS T32 AI007476NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

Yersinia pestis, the causative agent of plague, uses a type III secretion system (T3SS) to inject cytotoxic Yop proteins directly into the cytosol of mammalian host cells. The T3SS can also be activated in vitro at 37°C in the absence of calcium. The chromosomal gene rfaL (waaL) was recently identified as a virulence factor required for proper function of the T3SS. RfaL functions as a ligase that adds the terminal N-acetylglucosamine to the lipooligosaccharide core of Y. pestis. We previously showed that deletion of rfaL prevents secretion of Yops in vitro. Here we show that the divalent cations calcium, strontium, and magnesium can partially or fully rescue Yop secretion in vitro, indicating that the secretion phenotype of the rfaL mutant may be due to structural changes in the outer membrane and the corresponding feedback inhibition on the T3SS. In support of this, we found that the defect can be overcome by deleting the regulatory gene lcrQ. Consistent with a defective T3SS, the rfaL mutant is less virulent than the wild type. We show here that the virulence defect of the mutant correlates with a decrease in both T3SS gene expression and ability to inject innate immune cells, combined with an increased sensitivity to cationic antimicrobial peptides.

Indexed as

Bacterial Secretion SystemsAnimalsBacterial LoadBacterial ProteinsCations, DivalentDisease Models, AnimalFemaleGene DeletionLigasesMembrane Transport ProteinsMetalsMiceMice, Inbred C57BLPlagueSpleenVirulenceBacterial ProteinsBacterial Secretion SystemsCations, DivalentLigasesMembrane Transport ProteinsMetalsVirulence Factors

Identifiers

PMID23357388
PMCPMC3639585
OpenAlexW2147783577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.